Treatment with dapsone can have adverse effects such as hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient patients, methemoglobinemia, bone marrow suppression, and peripheral neuropathy. Here, G6PD is linked to peripheral neuropathy.